Circassia Pharmaceuticals PLC (Circassia) is a manufacturer and supplier of pharmaceutical products. The company has operations in Germany, the UK and the US. The company operates its business through three segments: allergy, respiratory and NIOX. Circassia‘s Allergy segment is engaged in the development of immunotherapy products for the treatment of allergy. The company’s respiratory segment relates to the portfolio of asthma and chronic obstructive pulmonary disease (COPD) product candidates. The company’s respiratory segment products include Duaklir, which is currently in phase III development for chronic obstructive pulmonary disease (COPD) in the United States. It operates respiratory segment through the partnership with AstraZeneca group of companies. Circassia‘s NIOX includes the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). The company promoted its NIOX products direct in the UK and Germany under NIOX brand name. Circassia currently operates 35 distribution network channels across Asia, Europe and the US. Circassia's subsidiaries include Circassia Limited, Circassia Pharma Limited, Circassia Pharmaceuticals Inc, Prosonix Limited, Aerocrine AB, Aerocrine Inc, Aerocrine GmbH, Aerocrine AG and Aerocrine Limited.
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of Circassia Pharmaceuticals PLC in terms of revenue, net income, and operating income.
-- Financials - Details about Circassia Pharmaceuticals PLC listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines Circassia Pharmaceuticals PLC’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases Circassia Pharmaceuticals PLC’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of Circassia Pharmaceuticals PLC’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does Circassia Pharmaceuticals PLC operate and what are key points about it?
-- What is the product / service portfolio of Circassia Pharmaceuticals PLC?
-- How has Circassia Pharmaceuticals PLC performed financially from the 2013?
-- How does Circassia Pharmaceuticals PLC rank among its peers in terms of revenue and market share?
-- What are Circassia Pharmaceuticals PLC strengths and weaknesses and what opportunities and threats does it face?
-- What are Circassia Pharmaceuticals PLC’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of Circassia Pharmaceuticals PLC? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years